Solifenacin Improved Warning Time Significantly Compared to Placebo in Patients with Overactive Bladder
Toglia M1, Andoh M2, Hussain I2 1. Urogynecology Associates of Philadelphia, Media, PA, 2. Astellas Pharma, Inc., Deerfield, IL
|
|
Abstract 123
|
|
|
Overactive Bladder - Basic Science and Clinical Practice:Main Auditorium
Scientific Podium Poster Session 14
|
|
|
Friday 1st December 2006 |
|
|
09:00 - 09:07 |
|
|